Hidetoshi Masumoto

Dr. Hidetoshi Masumoto

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MAMosha Abulaiti
Mosha Abulaiti
Yaxiaer YalikunYaxiaer Yalikun
Yaxiaer Yalikun
KMKozue Murata
Kozue Murata
ASAsako Sato
Asako Sato
MSMustafa M. Sami
Mustafa M. Sami
HMHidetoshi Masumoto
Hidetoshi Masumoto
Human iPS cell (iPSC)-derived cardiomyocytes (CMs) hold promise for drug discovery for heart diseases and cardiac toxicity tests. To utilize human iPSC-derived CMs, the establishment of three-dimensional (3D) heart tissues from iPSC-derived CMs and other heart cells, and a sensitive bioassay system to depict physiological heart function are anticipated. We have developed a heart-on-a-chip microdevice (HMD) as a novel system consisting of dynamic culture-based 3D cardiac microtissues derived from human iPSCs and microelectromechanical system (MEMS)-based microfluidic chips. The HMDs could visualize the kinetics of cardiac microtissue pulsations by monitoring particle displacement, which enabled us to quantify the physiological parameters, including fluidic output, pressure, and force. The HMDs demonstrated a strong correlation between particle displacement and the frequency of external electrical stimulation. The transition patterns were validated by a previously reported versatile video-based system to evaluate contractile function. The patterns are also consistent with oscillations of intracellular calcium ion concentration of CMs, which is a fundamental biological component of CM contraction. The HMDs showed a pharmacological response to isoproterenol, a β-adrenoceptor agonist, that resulted in a strong correlation between beating rate and particle displacement. Thus, we have validated the basic performance of HMDs as a resource for human iPSC-based pharmacological investigations.

2 August 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MIMasanosuke Ishigami
Masanosuke Ishigami
HMHidetoshi Masumoto
Hidetoshi Masumoto
TITakeshi Ikuno
Takeshi Ikuno
TATakayuki Aoki
Takayuki Aoki
MKMasahide Kawatou
Masahide Kawatou
KMKenji Minatoya
Kenji Minatoya
To realize human induced pluripotent stem cell (hiPSC)-based cardiac regenerative therapy, evidence of therapeutic advantages in human-sized diseased hearts are indispensable. In combination with an efficient and simultaneous differentiation of various cardiac lineages from hiPSCs and cell sheet technology, we aimed to generate clinical-sized large cardiac tissue sheets (L-CTSs) and to evaluate the therapeutic potential in porcine infarct heart. We simultaneously induced cardiomyocytes (CMs) and vascular cells [vascular endothelial cells (ECs) and vascular mural cells (MCs)] from hiPSCs. We generated L-CTSs using 10cm-sized temperature-responsive culture dishes. We induced myocardial infarction (MI) in micromini-pigs (15–25 kg) and transplanted the L-CTSs (Tx) 2 weeks after MI induction (4 sheets/recipient) under immunosuppression (Tx: n = 5, Sham: n = 5). Self-pulsating L-CTSs were approximately 3.5cm in diameter with 6.8×106±0.8 of cells containing cTnT+-CMs (45.6±13.2%), VE-cadherin+-ECs (5.3±4.4%) and PDGFRβ+-MCs (14.4±20.7%), respectively (n = 5). In Tx group, echocardiogram indicated a significantly higher systolic function of the left ventricle (LV) compared to that in sham control (Sham vs Tx: fractional shortening: 24.2±8.6 vs 40.5±9.7%; p<0.05). Ejection fraction evaluated by left ventriculogram was significantly higher in Tx group (25.3±6.2% vs 39.8±4.2%; p<0.01). Speckle tracking echocardiogram showed a significant increase of circumference strain in infarct and border regions after transplantation. Fibrotic area was significantly lower in Tx group (23.8±4.5 vs 15.9±3.8%; P<0.001). Capillary density in the border region was significantly higher in Tx group (75.9±42.6/mm2 vs 137.4±44.8/mm2, p<0.001). These data indicate that the L-CTS transplantation attenuated LV remodeling. L-CTSs potentially restore cardiac dysfunction of human-sized infarct heart.

1 June 2019 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
HNHiroomi Nishio
Hiroomi Nishio
HMHidetoshi Masumoto
Hidetoshi Masumoto
KSKazuhisa Sakamoto
Kazuhisa Sakamoto
KYKazuhiro Yamazaki
Kazuhiro Yamazaki
TITadashi Ikeda
Tadashi Ikeda
KMKenji Minatoya
Kenji Minatoya

14 May 2018 in Heart and Vessels
Verified
Journal Article
Closed access
PDF file
MKMotoyuki Kumagai
Motoyuki Kumagai
KMKenji Minakata
Kenji Minakata
HMHidetoshi Masumoto
Hidetoshi Masumoto
MYMasaya Yamamoto
Masaya Yamamoto
AYAtsushi Yonezawa
Atsushi Yonezawa
KMKenji Minatoya
Kenji Minatoya

1 October 2018 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
STShinichi Tsumaru
Shinichi Tsumaru
HMHidetoshi Masumoto
Hidetoshi Masumoto
KMKenji Minakata
Kenji Minakata
MIMasayasu Izuhara
Masayasu Izuhara
KYKazuhiro Yamazaki
Kazuhiro Yamazaki
KMKenji Minatoya
Kenji Minatoya

7 July 2018 in General Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
ZLZipeng Li
Zipeng Li
HMHidetoshi Masumoto
Hidetoshi Masumoto
JJJun-Ichiro Jo
Jun-Ichiro Jo
KYKazuhiro Yamazaki
Kazuhiro Yamazaki
TITadashi Ikeda
Tadashi Ikeda
KMKenji Minatoya
Kenji Minatoya